Inventurus Knowledge Solutions Limited has announced the approval of its unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. The company’s Board of Directors reviewed and approved these results during a meeting held on November 5, 2026. The detailed financial results and the limited review report from the statutory auditors are now available.
Inventurus Knowledge Solutions Board Approves Financial Results
Inventurus Knowledge Solutions Limited (the “Company”) has announced that its Board of Directors, in a meeting held on November 5, 2026, considered and approved the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026. This significant corporate action provides investors with updated financial performance data.
Key Financial Highlights
The approved financial results encompass the performance for the second quarter and the first half of the fiscal year. The accompanying documents include the limited review report issued by Price Waterhouse Chartered Accountants LLP, the Statutory Auditors of the Company. These results are now accessible on the Company’s website at https://ikshealth.com/investor-relations/.
Board Meeting Details
The Board Meeting, which commenced at 07:35 P.M. IST, concluded at 08:36 P.M. IST on November 5, 2026. The disclosure fulfills the requirements under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Source: BSE
